Imedex E-learning (audio)

Stephen B. Hanauer, MD, FACG: Optimizing therapy for mild to moderate IBD: Pearls for our foundational agents, 5-ASA, corticosteroids and immunomodulators

Informações:

Sinopsis

Webcast: Mastering Clinical Challenges and Emerging Therapies in IBD 2018